ClinicalTrials.govpublic full text
Safety, Tolerability and Activity of BIVV009 in Healthy Volunteers and Patients With Complement Mediated Disorders
bullous pemphigoid (bp), cold agglutinin disease (cad), warm autoimmune hemolytic anemia (waiha), end-stage renal disease (esrd), interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 895506
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.